- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Company's answer to a question about its factory channel versus core retail sales may be the best summation of its growth issues.
Third quarter results are in and they may be a preview of what to expect as the multi-level marketer changes its business model.
The company is experimenting with a promising new concept.
Western Union may have good opticals for its performance, but a dive into margins tells a different story.
An update on yellow-flagged Waste Management and red-flagged Usana Health Sciences.
Does it really want to explain itself quarter after quarter?
Careful about falling for the headline beat on Stericycle’s top and bottom lines.
Despite a good quarter, Intuitive still has some cautionary signs and Boulder Brands takes a hit on its pre-announcement.
I can't remember a time when so many big brands stumbled.
IBM proves the fallacy of a long-term estimate.